NRx Pharmaceuticals, Inc. ( NRXP) - Stock Earnings
NRXP Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 17, 2026, midnight | — / — | — | — / — | — |
NRXP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -5.9 million USD | 242000 USD |
| 2025Q4 | 360000 USD | 983000 USD |
| 2026Q1 | -1.4 million USD | 1.1 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
NRXP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.2 million USD | — USD |
| 2024 | -25.1 million USD | — USD |
| 2025 | -28.6 million USD | 1.2 million USD |
| 2026 Est. | — | — |
NRXP
Price: $3.44
52 week price:
Earnings Per Share: -1.04 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 246900
Market Capitalization: 52.5 million